Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue 
US 10-Year Treasury Yield at 6% Emerges as New Market Risk Threshold 
Gold Prices Fall as Treasury Yields Rise on Fed Rate Hike Bets 
Dollar Falls as Oil Eases, Yen Jumps on Intervention Signals 
Dollar Holds Near Two-Month High as Yen Approaches 160 
Gold Holds Near $4,275 as Rising Treasury Yields Fuel Fed Rate Hike Bets 
Fed’s Hammack Says Bond Yield Surge Is Not Driven by Inflation Fears 
Japanese Bank Stocks Surge as Bond Yields Fuel Rate Hike Bets 
Oil Prices Fall on U.S.-Iran Hormuz Deal Hopes 
UK PM Burnham to Unveil Economic Vision at Labour Conference 
Fed Unveils Stablecoin Rules Under GENIUS Act 
Japanese Yen Rebounds as Trump Flags Currency Weakness 
Trump, Xi Focus on Trade and AI at White House Summit 
Soybean Futures Slip as Traders Await Trump-Xi Trade Signals 
RBI Uses $10 Billion Currency Swaps to Drain Excess Rupee Liquidity 
Add as a preferred source on Google
U.S. stock futures soared Monday after the White House and Chinese officials reached a trade agreement, easing tensions between the world's two largest economies and fueling optimism across key sectors.
Apple (NASDAQ:AAPL) jumped 6.5% following the deal and a report from The Wall Street Journal indicating the tech giant may raise iPhone prices without directly attributing it to tariffs. Amazon (NASDAQ:AMZN) surged 7.6%, driven by its reliance on Chinese supply chains and the improved trade outlook.
Chinese stocks also gained significantly. Alibaba (NYSE:BABA), JD.com (NASDAQ:JD), and Baidu (NASDAQ:BIDU) all traded sharply higher, reflecting investor confidence in renewed U.S.-China cooperation.
Energy stocks rose alongside oil prices. Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) climbed about 2%, boosted by expectations of increased demand from the world’s top two oil consumers.
On the downside, pharmaceutical stocks slipped after President Donald Trump announced plans to slash prescription drug prices by 59%, though details remain unclear. Pfizer (NYSE:PFE), Eli Lilly (NYSE:LLY), and Johnson & Johnson (NYSE:JNJ) all declined over 2%. Additionally, Novo Nordisk (NYSE:NVO) fell 3% after Eli Lilly’s Zepbound outperformed Wegovy in a weight-loss drug trial.
Alphabet (NASDAQ:GOOGL) gained 2.8% following a DA Davidson analyst note suggesting that breaking up the Google parent company could unlock significant shareholder value.
Polestar (NASDAQ:PSNY) rose 3.7% after the EV maker posted a narrowed quarterly loss, signaling progress in cost-cutting and premium model sales. Monday.Com (NASDAQ:MNDY) rallied 5.9% after surpassing first-quarter earnings estimates and offering upbeat full-year guidance.
Overall, the market welcomed the trade truce, with tech, energy, and select growth stocks leading the rally.
